TEACH Feb 21 newsletter with Dr. Kuhl | Stryker,Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with ,ANXINWEI Safe Box, 0.8 Cubic Biometric Safe with Fireproof Waterproof Bag, Fireproof Safe with Dual Alarm System, Small Safe with Removable Shelf,